Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2004 030 553.7 |
96 | EP file number | EAKZ | 04 72 5035.2 |
86 | WO file number | WAKZ | PCT/EP2004/003479 |
97 | EP publication number | EPN | 1613599 |
87 | WO publication number | WPN | 2004087668 |
54 | Designation/title | TI | EIN VERFAHREN ZUR HERSTELLUNG VON 5-(HALOACETYL)-8-(SUBSTITUIERTES OXY)-(1H)-CHINOLIN-2-ONEN |
51 | IPC main class | ICM (ICMV) | C07D 215/26 (2006.01) |
22 | DE application date | DAT | Apr 1, 2004 |
96 | EP application date | EAT | Apr 1, 2004 |
86 | WO application date | WAT | Apr 1, 2004 |
43 | Date of first publication | OT | Oct 14, 2004 |
| Date of publication of grant | PET | Dec 15, 2010 |
71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH |
72 | Inventor | IN | LOHSE, Olivier, F-68170 Rixheim, FR; PENN, Gerhard, CH-4104 Oberwil, CH; SCHILLING, Hanspeter, CH-4103 Bottmingen, CH |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 459724 P Apr 2, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | LT, HR, LV, MK |
| Published EP/WO documents | EPWOPN | Original document:
EP000001613599 Searchable text:
EP000001613599 Original document:
EP000001613599B1 Searchable text:
EP000001613599B1 Original document:
WO002004087668 Searchable text:
WO002004087668 |
43 | Date of first publication | EVT | Oct 14, 2004 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 3, 2024 (Show all update days)(Hide all update days)- Sep 29, 2012
- Date of the first transfer into DPMAregister
|